Annals of Internal Medicine · 1987 · 187 citations · 26 references
MedicineImmunologyPulmonary Function TestingPulmonologyStem Cell TransplantationChronic Obstructive Pulmonary DiseaseForced Vital CapacityLung VolumesTransplant ComplicationsTransplant OutcomesAirflow MeasurementAirflow Obstruction AssessmentBaseline Airflow LimitationForced Expiratory Volume AssessmentForced Expiratory Volume DeclineForced Vital Capacity ChangeForced Vital Capacity RatioImmunosuppressive Drug Therapy
Obstructive lung disease is a complication of bone marrow transplantation. To identify risk factors we analyzed pulmonary function tests of 281 adult patients 1 year after marrow transplantation. The forced expiratory volume at 1 second divided by the forced vital capacity (FEV1/FVC) was used to measure airflow rates. Factors associated with a lower year-1 FEV1/FVC (%) included increased age (p less than 0.0001), male gender (p = 0.02), cigarette smoking (p = 0.01), lower FEV1/FVC before transplantation (p less than 0.0001), HLA-nonidentical grafts (p = 0.001), chronic graft-versus-host disease (p = 0.0002), and immunosuppressive therapy with methotrexate (p = 0.01). There was no significant association between the year-1 FEV1/FVC and underlying disease, dose of conditioning irradiation, or development of acute graft-versus-host disease. Linear multivariate regression analysis, after controlling for the FEV1/FVC before transplantation, shows both chronic graft-versus-host disease and administration of methotrexate independently associated with decrements in the year-1 FEV1/FVC. The combined occurrence of chronic graft-versus-host disease and methotrexate also was strongly associated with decreases in the year-1 FEV1/FVC, indicating an interaction of these risk factors.
26
Rainer Storb, H. Joachim Deeg, John Whitehead et al. · New England Journal of Medicine · 1986 · 1.5K citations
Medicine, Hematology, Immunology +14
Bronchiolitis Obliterans Organizing Pneumonia
Gary Epler · New England Journal of Medicine · 1985 · 1.1K citations